130096-70-7

Basic information

• Product Name: 3-Butenoic acid, 2-[[(phenylmethoxy)carbonyl]amino]-, phenylmethyl ester, (2S)-
• CAS NO: 130096-70-7
• Molecular Formula: C19H19NO4
• Molecular Weight: 325.364
• Mol File: 130096-70-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 3-Butenoic acid, 2-[[(phenylmethoxy)carbonyl]amino]-, phenylmethyl ester, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Butenoic acid, 2-[[(phenylmethoxy)carbonyl]amino]-, phenylmethyl ester, (2S)-(130096-70-7)
• EPA Substance Registry System: 3-Butenoic acid, 2-[[(phenylmethoxy)carbonyl]amino]-, phenylmethyl ester, (2S)-(130096-70-7)

Safety Data

• Hazardous Substances Data: 130096-70-7(Hazardous Substances Data)

Upstream product

• 58578-44-2 benzyl L-2-<(carbobenzxyloxy)amino>-4-hydroxybutyrate 
• 5680-86-4 N-benzyloxycarbonyl-5-O-benzyl-L-glutamic acid 
• 3705-42-8 Cbz-(L)-Glu-OBn 

Downstream Products

• 1554346-31-4 C₃₁H₃₅N₂O₉P 
• 1554346-34-7 C₂₂H₂₆NO₈P 
• 1554346-28-9 C₂₆H₃₄NO₈P 
• 1446694-12-7 C₂₇H₃₄NO₁₀P 
• 1446694-02-5 C₂₈H₃₆NO₁₀P 
• 130096-74-1 N-(3-tert-butoxy-3-oxopropyl)-L-(2-benzyl-5R-isoxazolidin-5-yl)glycin benzyl ester 
• 130096-75-2 (S)-(2-benzyl-5R-isoxazolidin-5-yl)(2-oxaazetidin-1-yl)acetic acid benzyl ester 
• 130096-73-0 L-(2-benzyl-5R-isoxazolidin-5-yl)glycin benzyl ester 
• 856668-32-1 benzyl (2S)-5-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2-(benzyloxycarbonylamino)pent-3-enoate 
• 856668-33-2 benzyl (2S)-6-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-2-(benzyloxycarbonylamino)hex-3-enoate 
• 217965-29-2 4-(2-{4-[5-((S)-Benzyloxycarbonyl-benzyloxycarbonylamino-methyl)-4,5-dihydro-isoxazol-3-yl]-phenoxy}-ethyl)-piperidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Continuous-flow thermolysis for the preparation of vinylglycine derivatives

Syn sulfoxide elimination was carried out under continuous-flow conditions in a mesofluidic thermolysis reactor. The design of the reactor enabled accurate control of reaction time and conditions, affording a convenient scale-independent procedure for the production of N,C-protected vinylglycine derivatives. Thermolysis at 270 °C under 1000 psi of pressure in superheated toluene enabled typical daily outputs ranging from 11 to 46 g per day with excellent selectivities and ee (>97%). The various competitive reaction pathways were studied and rationalized according to a computational study.

C-linked galactosyl serine AFGP analogues as potent recrystallization inhibitors

(Chemical Equation Presented) A series of C-linked antifreeze glycoprotein analogues have been prepared to evaluate antifreeze activity as a function of distance between the carbohydrate moiety and polypeptide backbone. The building blocks for these analogues were prepared using either an olefin cross-metathesis or catalytic asymmetric hydrogenation. Analysis of antifreeze protein-specific activity revealed that only analogue 2a (n = 1) was a potent recrystallization inhibitor and thus has potential medical and industrial applications.

Isoxazoline and isoxazole fibrinogen receptor antagonists

This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex or the vitronectin receptor, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.